AFS
WST icon

Aft Forsyth & Sober’s West Pharmaceutical WST Stock Holding History

Aft Forsyth & Sober’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,700
Closed -$1.39M – 87
2023
Q3 		$1.39M Hold
3,700
– – 0.59% 46
2023
Q2 		$1.42M Hold
3,700
– – 0.59% 49
2023
Q1 		$1.28M Hold
3,700
– – 0.65% 49
2022
Q4 		$871K Hold
3,700
– – 0.39% 73
2022
Q3 		$910K Hold
3,700
– – 0.44% 67
2022
Q2 		$1.12M Hold
3,700
– – 0.52% 58
2022
Q1 		$1.52M Hold
3,700
– – 0.6% 46
2021
Q4 		$1.74M Hold
3,700
– – 0.61% 39
2021
Q3 		$1.57M Buy
+3,700
New +$1.56M 0.59% 45

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aft Forsyth & Sober's WST Position: Q4 2023 in Review

Aft Forsyth & Sober sold out of West Pharmaceutical (WST) in Q4 2023, closing a stake of 3,700 shares — an estimated $1.39M sold.

Aft Forsyth & Sober first reported a position in WST in Q3 2021 and held it in 9 quarters. The position peaked at $1.74M in Q4 2021. 782 funds tracked by Wall St. Rank hold WST as of Q4 2023.

  • Aft Forsyth & Sober reported no remaining West Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Aft Forsyth & Sober sold 3,700 West Pharmaceutical shares in Q4 2023, an estimated $1.39M.
  • Aft Forsyth & Sober first reported a position in West Pharmaceutical in Q3 2021 and held it in 9 quarters.
  • Aft Forsyth & Sober's West Pharmaceutical position peaked at $1.74M in Q4 2021.
  • 782 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.

Based on Aft Forsyth & Sober's 13F filing for Q4 2023, filed 8 Feb 2024.